Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory Bowel Disease–Associated Changes in the Gut: Focus on Kazan Patients
Giuseppe Lo Sasso, Lusine Khachatryan, Athanasios Kondylis, et al.
Inflammatory Bowel Diseases (2020) Vol. 27, Iss. 3, pp. 418-433
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease
Spase Stojanov, Aleš Berlec, Borut Štrukelj
Microorganisms (2020) Vol. 8, Iss. 11, pp. 1715-1715
Open Access | Times Cited: 1256
Regulatory role of short-chain fatty acids in inflammatory bowel disease
Zhilin Zhang, Huan Zhang, Tian Chen, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 140
The potential of Akkermansia muciniphila in inflammatory bowel disease
Ting Zhang, Xinghui Ji, Gaochen Lu, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 14-15, pp. 5785-5794
Closed Access | Times Cited: 130
Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease
Laila Aldars‐García, María Chaparro, Javier P. Gisbert
Microorganisms (2021) Vol. 9, Iss. 5, pp. 977-977
Open Access | Times Cited: 127
Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease
Yongjia Hu, Zhouzhou Chen, Chengchen Xu, et al.
Nutrients (2022) Vol. 14, Iss. 23, pp. 5140-5140
Open Access | Times Cited: 70
The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease
Dickson Kofi Wiredu Ocansey, Sanhua Hang, Xinyi Yuan, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 42
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
Antonio Pellegrino, Gaetano Coppola, Francesco Santopaolo, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 1815-1815
Open Access | Times Cited: 42
Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome
I. F. Shaidullov, D. M. Sorokina, Ф. Г. Ситдиков, et al.
BMC Gastroenterology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 61
Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
Mengfan Li, Lijiao Yang, Chenlu Mu, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 2402-2414
Open Access | Times Cited: 55
The evolving role of methanogenic archaea in mammalian microbiomes
James G. Volmer, Harley McRae, Mark Morrison
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 22
The emerging role of the gut microbiota and its application in inflammatory bowel disease
Wang Xiu, Jianhua Peng, Pei-Pei Cai, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117302-117302
Open Access | Times Cited: 11
The Anti-inflammatory Potential of a Strain of Probiotic Bifidobacterium pseudocatenulatum G7: In Vitro and In Vivo Evidence
Yukun Sun, Jiazhi Zhou, Hengjun Du, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 18, pp. 10355-10365
Closed Access | Times Cited: 8
Insights into the Mechanisms of Action of Akkermansia muciniphila in the Treatment of Non-Communicable Diseases
Honorata Mruk-Mazurkiewicz, Monika Kulaszyńska, Wiktoria Czarnecka, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1695-1695
Open Access | Times Cited: 8
The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review
Laila Aldars‐García, Alicia C Marín, María Chaparro, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3076-3076
Open Access | Times Cited: 53
Short‐chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
Kaixin Peng, Suhong Xia, Siqi Xiao, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 9, pp. 1710-1718
Closed Access | Times Cited: 28
Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome?
Bhupinder Kapoor, Monica Gulati, Reena Gupta, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 5, pp. 103313-103313
Closed Access | Times Cited: 16
2′-Fucosyllactose Promotes Colonization of Akkermansia muciniphila and Prevents Colitis In Vitro and in Mice
Xiaoxia Liu, Bowei Zhang, Yunhui Zhang, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 9, pp. 4765-4776
Closed Access | Times Cited: 6
Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota–Gut–Brain Axis
Elena Layunta, Berta Buey, José Emilio Mesonero, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 33
Akkermansia muciniphila - friend or foe in colorectal cancer?
Ekaterina O. Gubernatorova, Е. А. Горшкова, Marina Bondareva, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Constituents of stable commensal microbiota imply diverse colonic epithelial cell reactivity in patients with ulcerative colitis
Rūta Inčiūraitė, Rolandas Gedgaudas, Rokas Lukoševičius, et al.
Gut Pathogens (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Rosemary (Rosmarinus officinalis L.) polyphenols and inflammatory bowel diseases: Major phytochemicals, functional properties, and health effects
Lianhua Zhang, J. M. Lü
Fitoterapia (2024) Vol. 177, pp. 106074-106074
Closed Access | Times Cited: 5
Impact of Microbiota Diversity on Inflammatory Bowel Disease
Ashwag Jaman Al-zahrani, Basma M. Al-Hebshi, Zolfekar A. Yahia, et al.
Microorganisms (2025) Vol. 13, Iss. 4, pp. 710-710
Open Access
Anti-inflammatory and gut microbiota modulatory effects of polysaccharides from Fuzhuan brick tea on colitis in mice induced by dextran sulfate sodium
Ziqi Zeng, Zhi Xie, Guijie Chen, et al.
Food & Function (2021) Vol. 13, Iss. 2, pp. 649-663
Closed Access | Times Cited: 28
Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway
Xin Wen, Rui Xie, Honggang Wang, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 30, pp. 4657-4670
Open Access | Times Cited: 12
Fermented pea yoghurt mitigates DSS induced ulcerative colitis through gut microbiota modulation and enhanced SCFA production in a mouse model
Mengdi Zhao, Yuanyuan Zhang, Yi Wu, et al.
Food Bioscience (2025) Vol. 65, pp. 106046-106046
Open Access
Page 1 - Next Page

Scroll to top